Company: PSTV
Filing Date: 2025-07-11
Form Type: PRE 14A
Source: 0001140361-25-025650
Chunk: 79

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-07-11
Form: PRE 14A
Chunk 79
---
| Weighted-average remaining term of outstanding stock options                                          |     | 9.16 years |
| Total number of shares of Common Stock subject to outstanding full value awards                       |     |          0 |
| Total number of shares of Common Stock available for grant under the 2020 Plan                        |     |     47,409 |
| Total number of shares of Common Stock available for grant under the 2015 New Employee Incentive Plan |     |     76,025 |
| Total number of shares of Common Stock outstanding                                                    |     | 60,490,101 |
| Per-share closing price of Common Stock as reported on the Nasdaq Capital Market                      |     |      $0.20 |

To provide the Company the flexibility to responsibly address our future equity compensation needs, we are requesting that stockholders approve the Fifth Amended Plan to make an additional 20,000,000 shares available for grant. Grant levels for the preceding three (3) fiscal years have averaged 191,805 shares per year.

51

TABLE OF CONTENTS

The following table shows our key dilution metrics over the last three years:

| Key Equity Metrics      |     | Three-Year 
 Average    |     |   2024 |     |  2023 |     |   2022 |
| Net Equity Burn Rate(1) |     | 2.96%      |     |   6.9% |     | 1.97% |     |  0.02% |
| Dilution(2)             |     | 5.46%      |     |  9.72% |     | 3.15% |     |  3.50% |
| Overhang(3)             |     | 11.76%     |     | 18.03% |     | 6.85% |     | 10.40% |

| (1) | Net Equity Burn Rate is calculated by dividing (i) the difference between (a) number of shares subject to equity awards granted during the year, (b) minus shares subject to awards that were cancelled or forfeited during the year, by (ii) the weighted average number of shares outstanding during the year. |

| (2) | Dilution is calculated by dividing (i) the number of shares subject to equity awards outstanding at the end of the year by (ii) the number of shares outstanding at the end of the year. |

| (3)